Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease.
Front Aging Neurosci
; 15: 1134111, 2023.
Article
in En
| MEDLINE
| ID: mdl-37213535
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Screening_studies
Language:
En
Journal:
Front Aging Neurosci
Year:
2023
Document type:
Article
Affiliation country:
Spain
Country of publication:
Switzerland